Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 452.20
-21.00 (-4.44%)
Oct 22, 2026, 2:05 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 108.09 billion as of October 21, 2026. It is the 1,618th most valuable company in the world and the 84th biggest in Hong Kong. Its market cap has decreased by 1.59% in one year.
Market Cap
108.09B
Enterprise Value
102.66B
Revenue
2.41B
Global Rank
Country Rank
#84 Hong Kong
PE Ratio
604.26
ChartMarket Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 108.09B, an increase of 701.28%. That is a compound annual growth rate of 88.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 108.09B | 18.18% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 330.91B |
| WuXi Biologics | 205.39B |
| Innovent Biologics | 152.16B |
| Sino Biopharmaceutical | 96.17B |
| Akeso | 84.19B |
| Genscript Biotech | 76.21B |
| RemeGen | 54.01B |
| Biocytogen Pharmaceuticals (Beijing) | 37.86B |